Publicaciones en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (16)

2023

  1. Hematological Composite Scores in Patients with Inflammatory Bowel Disease

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  2. Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease

    International journal of molecular sciences, Vol. 24, Núm. 6

2022

  1. Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease

    Clinical and translational gastroenterology, Vol. 13, Núm. 6, pp. e00500

  2. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

    Frontiers in Medicine, Vol. 9

  3. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  4. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

    Journal of Clinical Medicine, Vol. 11, Núm. 2

  5. Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 668-676

  6. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry

    Digestive and Liver Disease, Vol. 54, Núm. 5, pp. 635-641

  7. Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)

    Journal of Clinical Medicine, Vol. 11, Núm. 24

  8. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2021

  1. Carotid plaque assessment reclassifies patients with inflammatory bowel disease into very-high cardiovascular risk

    Journal of Clinical Medicine, Vol. 10, Núm. 8

  2. Diet and microbiome in the beginning of the sequence of gut inflammation

    World Journal of Clinical Cases, Vol. 9, Núm. 36, pp. 11122-11147

  3. Insulin resistance is not increased in inflammatory bowel disease patients but is related to non-alcoholic fatty liver disease

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  4. Qrisk3 performance in the assessment of cardiovascular risk in patients with inflammatory bowel disease

    Journal of Clinical Medicine, Vol. 10, Núm. 18

2020

  1. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry

    Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616

  2. Factores predictores de la respuesta clínica al tratamiento con anti-TNF en colitis ulcerosa: ¿qué hemos aprendido de nuestros pacientes?

    Revista Espanola de Enfermedades Digestivas, Vol. 112, Núm. 8, pp. 636-641